Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy

Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy

The lost dopaminergic neurons in the brain prevent mobility in Parkinson's disease (PD). It is impossible to stop the disease's progress by means of symptoms management. Research focuses on oxidative stress, mitochondrial dysfunction, and neuronal degeneration. Exploration of potential neu...

Full description

Bibliographic Details
Main Authors: Khalid M. Alharthy, Summya Rashid, Hasan S. Yusufoglu, Saleh I. Alqasoumi, Majid Ahmad Ganaie, Aftab Alam
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Saudi Pharmaceutical Journal
Subjects:
Parkinson's disease
Dopaminergic neurons
Bcl-2
Reserpine
Antioxidant
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016423004231

Internet

http://www.sciencedirect.com/science/article/pii/S1319016423004231

Similar Items